Evidence map›Paper›PMID 27242707›Full record

ArticleFrontiers in microbiology2016

Horizontal Acquisition of a Multidrug-Resistance Module (R-type ASSuT) Is Responsible for the Monophasic Phenotype in a Widespread Clone of Salmonella Serovar 4,[5],12:i:.

Patricia García, Burkhard Malorny, M Rosario Rodicio, Roger Stephan, Herbert Hächler, Beatriz Guerra, Claudia Lucarelli

Open access · goldAbstract read
In one paragraph

Article in Frontiers in microbiology, 2016. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 32 papers.

0numbers the graph read from it
0cells of the map it votes in
32citing papers in PubMed
7.0field-weighted citation impact, top 4% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

32 citing papers in PubMed, 51 citations in OpenAlex.

  1. Article
  2. Emergence ofFrontiers in microbiology · 2026
    Article
  3. Article
  4. Localization of the origin of transfer for Salmonella genomic island 4 from Salmonella enterica serovar I 4,[5],12:i:.DNA research : an international journal for rapid publication of reports on genes and genomes · 2025
    Article
  5. ISMicrobiology and molecular biology reviews : MMBR · 2024
    Review
  6. Article
  7. Article
  8. Spread ofAntibiotics (Basel, Switzerland) · 2023
    Article
  9. Article
  10. Article
  11. Article
  12. Article
  13. Article
  14. Article
  15. Article
  16. Colistin Resistance in Monophasic Isolates ofFrontiers in microbiology · 2021
    Article
  17. Article
  18. Article
  19. Genotyping Study ofMicroorganisms · 2020
    Article
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

7 authors at 4 institutions in 5 countries.

Patricia GarcíaDepartment of Functional Biology, Area of Microbiology, University of Oviedo Oviedo, Spain.
Burkhard MalornyDepartment of Biological Safety, Federal Institute for Risk Assessment Berlin, Germany.
M Rosario RodicioDepartment of Functional Biology, Area of Microbiology, University of Oviedo Oviedo, Spain.
Roger StephanVetsuisse Faculty, National Centre for Enteropathogenic Bacteria and Listeria, Institute for Food Safety and Hygiene, University of Zurich Zürich, Switzerland.
Herbert HächlerVetsuisse Faculty, National Centre for Enteropathogenic Bacteria and Listeria, Institute for Food Safety and Hygiene, University of Zurich Zürich, Switzerland.
Beatriz GuerraDepartment of Biological Safety, Federal Institute for Risk Assessment Berlin, Germany.
Claudia LucarelliDepartment of Infectious, Parasitic and Immuno-Mediated Diseases, Istituto Superiore di SanitàRome, Italy; European Public Health Microbiology Training Programme, European Centre for Disease Prevention and ControlStockholm, Sweden.
Federal Institute for Risk Assessment · DEUniversidad de Oviedo · ESUniversity of Zurich · CHIstituto Superiore di Sanità · IT

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Salmonella enterica serovar 4,[5],12:i:- is a monophasic variant of S. Typhimurium incapable of expressing the second-phase flagellar antigen (fljAB operon), and it is recognized to be one of the most prevalent serovars causing human infections. A clonal lineage characterized by phage type DT193, PulseNet PFGE profile STYMXB.0131 and multidrug resistance to ampicillin, streptomycin, sulphonamides and tetracycline (R-type ASSuT) is commonly circulating in Europe. In this study we determined the deletions affecting the fljAB operon and the resistance region responsible for the R-type ASSuT in a strain of Salmonella enterica serovar 4,5,12:i:- DT193/STYMXB.0131, through an approach based on PCRs and Southern blot hybridization of genomic DNA. Using a set of nine specific PCRs, the prevalence of the resistance region was assessed in a collection of 144 S. enterica serovar 4,[5],12:i:-/ASSuT/STYMXB.0131 strains isolated from Germany, Switzerland and Italy. A 28 kb-region is embedded between the loci STM2759 and iroB, replacing the DNA located in between, including the fljAB operon. It encompasses the genes bla TEM-1, strA-strB, sul2 and tet(B) responsible for the R-type ASSuT together with genes involved in plasmid replication and orfs of unknown function characteristically located on IncH1 plasmids. Its location and internal structure is fairly conserved in S. enterica serovar 4,[5],12:i:-/ASSuT/STYMXB.0131 strains regardless of the isolation source or country. Hence, in the S. enterica serovar 4,[5],12:i:-/ASSuT/STYMXB.0131 clonal lineage widespread in Germany, Switzerland and Italy, a resistance region derived from IncH1 plasmids has replaced the chromosomal region encoding the second flagellar phase and is an example of the stabilization of new plasmid-derived genetic material due to integration into the bacterial chromosome.

Indexed as

antimicrobial resistanceEuropean clonemolecular epidemiologymonophasic Salmonellaplasmid origin

Identifiers

PMID27242707
PMCPMC4861720
OpenAlexW2415984947

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.